Active Ingredient History

NOW
  • Now
CRESTOR (rosuvastatin calcium) is an inhibitor of HMG-CoA reductase. It has been widely launched for the treatment of patients with dyslipidaemia and has also been approved in the US and EU to slow the progression of atherosclerosis.   NCATS

  • SMILES: CC(C)c1nc(nc(c2ccc(F)cc2)c1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(=O)(=O)C
  • InChIKey: BPRHUIZQVSMCRT-VEUZHWNKSA-N
  • Mol. Mass: 481.55
  • ALogP: 2.4
  • ChEMBL Molecules:
More Chemistry
  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$0.0739 - $0.2835
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

(3r,5s,6e)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid | (3r,5s,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid | 7-(4-(4-fluorophenyl)-6-isopropyl-2-(n-methyl-n-methanesulfonylaminopyrimidin)-5-yl)-3,5-dihydroxy-6-heptenoic acid | crestor | hcp1306 | rosuvastatin | rosuvastatin calcium | rosuvastatin zinc | s 4522 | s-4522 | zd4522 | zd-4522 | zd-4522 (calcium salt)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue